{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:06:13Z","timestamp":1789538773916,"version":"build-2803163510"},"reference-count":35,"publisher":"International Union Against Tuberculosis and Lung Disease","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJTLD Open"],"accepted":{"date-parts":[[2026,5,27]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>All-oral shortened regimens for multidrug\/rifampicin-resistant TB (MDR\/RR-TB) commonly include cycloserine, which is associated with neuropsychiatric toxicity. Predictors of cycloserine-related adverse events remain poorly defined. We assessed whether baseline anaemia or hypoalbuminemia predict neuropsychiatric toxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We conducted a prospective cohort study of three 9-month standardised MDR\/RR-TB regimens in Kazakhstan. Regimens shared a core of a fluoroquinolone, bedaquiline, and linezolid; one regimen included cycloserine. Neuropsychiatric adverse events of special interest (AESIs) included peripheral neuropathy, seizures, and psychosis. We conducted logistic regression to calculate associations between baseline anaemia and hypoalbuminemia and neuropsychiatric or central nervous system (CNS)-specific AESIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      In 556 cycloserine-treated individuals, 29 (5.2%) developed neuropsychiatric AESIs. Adjusted odds ratios comparing anaemia vs. no anaemia were 2.40 (95% confidence interval [CI]: 1.01\u20135.72) for neuropsychiatric AESIs and 2.71 (95% CI: 0.74\u20139.91) for CNS-specific AESIs. Adjusted odds ratios for grade \u22652 hypoalbuminemia were 3.59 (95% CI: 0.88\u201314.60) and 7.40 (95% CI: 1.58\u201334.66), respectively. In 146 individuals without cycloserine, neuropsychiatric AESI occurred in 0\/49 with anaemia versus 5\/97 without anaemia (0% vs 5.2%;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.168), and in 1\/3 with grade \u22652 hypoalbuminemia versus 3\/90 without (33.3% vs 3.3%; Fisher\u2019s exact\n                      <jats:italic>P<\/jats:italic>\n                      = 0.125).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Baseline anaemia and hypoalbuminemia were associated with increased neuropsychiatric toxicity risk during treatment with a cycloserine-containing regimen. Whether these associations are specific to cycloserine merits further study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5588\/ijtldopen.26.0098","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:50:36Z","timestamp":1789537836000},"page":"592-597","source":"Crossref","is-referenced-by-count":0,"title":["Anaemia, hypoalbuminemia, and risk of cycloserine-associated neuropsychiatric toxicity in a shortened oral regimen for multidrug\/rifampicin-resistant TB"],"prefix":"10.5588","volume":"3","author":[{"given":"E.Q.L.","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rashitov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Algozhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Arlyapova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Skrahina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"LaHood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Trevisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Osso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Romo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.J.","family":"Seung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.D.","family":"Mitnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Algozhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3554","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"2026091522503202000_3.9.592.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2400327"},{"key":"2026091522503202000_3.9.592.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00313-8"},{"key":"2026091522503202000_3.9.592.3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae305"},{"key":"2026091522503202000_3.9.592.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2117166"},{"issue":"22","key":"2026091522503202000_3.9.592.5","first-page":"2164","article-title":"A pragmatic trial of a 6-month strategy for rifampicin-resistant tuberculosis","volume":"394","author":"Conradie","year":"2026","journal-title":"N Engl J Med"},{"issue":"3","key":"2026091522503202000_3.9.592.6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5588\/ijtldopen.25.0553","article-title":"Effectiveness and safety of a shortened oral regimen for rifampicin- or multidrug-resistant TB","volume":"3","author":"Herrera-Flores","year":"2026","journal-title":"IJTLD Open"},{"key":"2026091522503202000_3.9.592.7","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijid.2021.03.001","article-title":"Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis","volume":"105","author":"Court","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"5","key":"2026091522503202000_3.9.592.8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/medicina61050911","article-title":"The adverse effects of tuberculosis treatment: a comprehensive literature review","volume":"61","author":"Mere\u0161kevi\u010dien\u0117","year":"2025","journal-title":"Medicina"},{"key":"2026091522503202000_3.9.592.9","doi-asserted-by":"publisher","DOI":"10.1039\/c003743e"},{"issue":"19","key":"2026091522503202000_3.9.592.10","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1111\/febs.16455","article-title":"Cycloserine enantiomers inhibit PLP-dependent cysteine desulfurase SufS via distinct mechanisms","volume":"289","author":"Nakamura","year":"2022","journal-title":"FEBS J"},{"key":"2026091522503202000_3.9.592.11","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(89)90379-0"},{"key":"2026091522503202000_3.9.592.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00073-9"},{"key":"2026091522503202000_3.9.592.13","unstructured":"World Health Organization . WHO operational handbook on tuberculosis, Module 3, Web Annex B. Critical concentrations for pretomanid and cycloserine. Geneva: WHO, 2024."},{"key":"2026091522503202000_3.9.592.14","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv102"},{"key":"2026091522503202000_3.9.592.15","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00028"},{"key":"2026091522503202000_3.9.592.16","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2016.199"},{"key":"2026091522503202000_3.9.592.17","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00055-19"},{"key":"2026091522503202000_3.9.592.18","unstructured":"M\u00e9decins Sans Fronti\u00e8res . MSF Severity Grading Scale (version 5.0). Paris, France: M\u00e9decins Sans Fronti\u00e8res (MSF), 2016. endtb.org\/resources\/pharmacovigilance."},{"key":"2026091522503202000_3.9.592.19","unstructured":"World Health Organization . Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: WHO, 2024."},{"key":"2026091522503202000_3.9.592.20","doi-asserted-by":"crossref","first-page":"4946848","DOI":"10.1155\/2022\/4946848","article-title":"Value of postoperative serum albumin to predict postoperative complication severity in spinal tuberculosis","volume":"2022","author":"Jiang","year":"2022","journal-title":"Biomed Res Int"},{"issue":"1","key":"2026091522503202000_3.9.592.21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1186\/s12879-016-2062-5","article-title":"Predictive factors for unfavorable outcomes of tuberculous pericarditis in human immunodeficiency virus-uninfected patients in an intermediate tuberculosis burden country","volume":"16","author":"Jung","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2026091522503202000_3.9.592.22","doi-asserted-by":"crossref","first-page":"100843","DOI":"10.1016\/j.cegh.2021.100843","article-title":"The factors predicting mortality in pulmonary tuberculosis with acute respiratory failure","volume":"12","author":"Maranatha","year":"2021","journal-title":"Clin Epidemiol Glob Health"},{"issue":"21","key":"2026091522503202000_3.9.592.23","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.3390\/jcm10215134","article-title":"Severe hypoalbuminemia at admission is strongly associated with worse prognosis in older adults with SARS-CoV-2 infection","volume":"10","author":"Arnau-Barres","year":"2021","journal-title":"J Clin Med"},{"issue":"3","key":"2026091522503202000_3.9.592.24","doi-asserted-by":"crossref","first-page":"e0283623","DOI":"10.1371\/journal.pone.0283623","article-title":"Association between hypoalbuminemia and mortality in patients undergoing continuous renal replacement therapy: a systematic review and meta-analysis","volume":"18","author":"Wang","year":"2023","journal-title":"PLoS One"},{"key":"2026091522503202000_3.9.592.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.12.007"},{"issue":"12","key":"2026091522503202000_3.9.592.26","doi-asserted-by":"crossref","first-page":"e0143725","DOI":"10.1128\/spectrum.01437-25","article-title":"Cycloserine-induced neuropsychiatric toxicity in multidrug-resistant tuberculosis: association with peak plasma concentration","volume":"13","author":"Cheng","year":"2025","journal-title":"Microbiol Spectr"},{"key":"2026091522503202000_3.9.592.27","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0863"},{"key":"2026091522503202000_3.9.592.28","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.2147\/IDR.S369715","article-title":"High incidence of psychiatric disorders associated with cycloserine treatment of multidrug-resistant tuberculosis patients: a cohort study in Beijing, China","volume":"15","author":"Pang","year":"2022","journal-title":"Infect Drug Resist"},{"key":"2026091522503202000_3.9.592.29","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2147\/IDR.S195555","article-title":"Cycloserine for treatment of multidrug-resistant tuberculosis: a retrospective cohort study in China","volume":"12","author":"Li","year":"2019","journal-title":"Infect Drug Resist"},{"key":"2026091522503202000_3.9.592.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2013.06.015"},{"issue":"1","key":"2026091522503202000_3.9.592.31","doi-asserted-by":"crossref","first-page":"2551822","DOI":"10.1080\/07853890.2025.2551822","article-title":"Risk factors of linezolid-associated hyponatremia from a retrospective case-control study: decreased serum albumin as a selective predictor in elder patients","volume":"57","author":"Liang","year":"2025","journal-title":"Ann Med"},{"issue":"11","key":"2026091522503202000_3.9.592.32","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ebiom.2015.09.051","article-title":"Linezolid trough concentrations correlate with mitochondrial toxicity-related adverse events in the treatment of chronic extensively drug-resistant tuberculosis","volume":"2","author":"Song","year":"2015","journal-title":"EBioMedicine"},{"issue":"1","key":"2026091522503202000_3.9.592.33","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1017\/ash.2024.487","article-title":"Linezolid and tedizolid adverse effects: a review on serotonin syndrome, myelosuppression, neuropathies, and lactic acidosis","volume":"5","author":"Greenfield","year":"2025","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"1","key":"2026091522503202000_3.9.592.34","doi-asserted-by":"crossref","first-page":"26913","DOI":"10.1038\/s41598-025-11432-w","article-title":"Past, current status, and future trends of the rural healthcare network in the Republic of Kazakhstan","volume":"15","author":"Jobalayeva","year":"2025","journal-title":"Sci Rep"},{"issue":"5","key":"2026091522503202000_3.9.592.35","first-page":"58","article-title":"The prevalence of anemia among children and women of reproductive age in Kazakhstan and basis of its prevention","volume":"82","author":"Smagulova","year":"2013","journal-title":"Vopr Pitan"}],"container-title":["IJTLD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.5588\/ijtldopen.26.0098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:50:40Z","timestamp":1789537840000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.theunion.org\/lookup\/doi\/10.5588\/ijtldopen.26.0098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,1]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.5588\/ijtldopen.26.0098"],"URL":"https:\/\/doi.org\/10.5588\/ijtldopen.26.0098","relation":{},"ISSN":["3005-7590"],"issn-type":[{"value":"3005-7590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}